Celgene : CELG

All CELG Articles

433 Articles

Jon C. Ogg | Dec 5, 2013 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Citigroup, Exxon, Sprint, Tiffany and More

ThinkstockStocks have pulled back ahead of the jobs data, and investors need to be considering how to position their portfolios…

Jon C. Ogg | Dec 3, 2013 at 11:35 AM EST

Celgene Gets OncoMed Cancer Pipeline, Maybe Dirt Cheap

OncoMed Pharmaceuticals just went from being an obscure biotech to one on the map with more security than it had.…

Jon C. Ogg | Oct 8, 2013 at 2:47 PM EDT

Market Take: Biotech Suffers Under Government Shutdown Too!

ThinkstockThe field of pharmaceuticals is very well established and often is considered to be a very defensive sector. As such,…

Jon C. Ogg | Oct 8, 2013 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Celgene, J.C. Penney, Whole Foods and More

Jon OggStocks have traded down from recent highs in light of a federal government shutdown and ahead of a debt…

Lee Jackson | Oct 3, 2013 at 11:50 AM EDT

Top Biotechs Set to Win in the War on Cancer

ThinkstockTuesday saw the wrap up of the 2013 European Society of Medical Oncology (ESMO) conference in Amsterdam, which featured key…

Jon C. Ogg | Jun 13, 2013 at 8:15 AM EDT

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale…

Trey Thoelcke | May 16, 2013 at 7:30 AM EDT

Top New Biotech Ideas From PropThink

ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug…

Jon C. Ogg | May 15, 2013 at 8:10 AM EDT

Deutsche Bank Firm on Biotech Stocks to Buy

ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and…

Jon C. Ogg | May 1, 2013 at 10:45 AM EDT

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Jon OggBiotech stocks come and go as far as the flavor of the day for investors. While many of these…

Jon C. Ogg | Apr 5, 2013 at 8:15 AM EDT

Top Analyst Upgrades and Downgrades (CELG, CMCSA, FB, FFIV, JPM, JNPR, KMB, NWSA, PDCE, AET, CI, HUM, UNH, WLP)

Jon OggInvestors and traders are usually on the hunt for new ideas that will generate positive returns or income. 24/7…

Jon C. Ogg | Feb 28, 2013 at 12:50 PM EST

ETF Folly: Biotech ETFs, Nothing but Confusion

Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or…

Jon C. Ogg | Feb 20, 2013 at 12:30 PM EST

Major Companies Hitting All-Time Highs! (AWK, AWR, BRK-B, UNP, HON, MMM, CELG, GOOG, CL, KMB, PG, CLX, URI, DIS)

courtesy of the Walt Disney Co.You know it is a bull market when you see major household names hitting 52-week…

Jon C. Ogg | Feb 20, 2013 at 9:10 AM EST

Celgene: When Biotechs Use Stock Buybacks to Juice Price and Earnings

ThinkstockWhen companies start buying back their common stock on the open market, it can have multiple outcomes. It can offset…

Jon C. Ogg | Feb 8, 2013 at 10:10 AM EST

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited…

Jon C. Ogg | Jan 28, 2013 at 8:31 AM EST

Top Analyst Upgrades and Downgrades (AKS, AAPL, BBBY, BBY, CELG, CMG, FB, FURX, HBHC, HEP, NWSA, PAA, QCOM, TEX, VMW)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Monday.…

1 … 21 22 23 24 25 … 29

Celgene : CELG

All CELG Articles

Top Analyst Upgrades and Downgrades: Citigroup, Exxon, Sprint, Tiffany and More

Celgene Gets OncoMed Cancer Pipeline, Maybe Dirt Cheap

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Analyst Upgrades and Downgrades: Celgene, J.C. Penney, Whole Foods and More

Top Biotechs Set to Win in the War on Cancer

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Top New Biotech Ideas From PropThink

Deutsche Bank Firm on Biotech Stocks to Buy

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Top Analyst Upgrades and Downgrades (CELG, CMCSA, FB, FFIV, JPM, JNPR, KMB, NWSA, PDCE, AET, CI, HUM, UNH, WLP)

ETF Folly: Biotech ETFs, Nothing but Confusion

Major Companies Hitting All-Time Highs! (AWK, AWR, BRK-B, UNP, HON, MMM, CELG, GOOG, CL, KMB, PG, CLX, URI, DIS)

Celgene: When Biotechs Use Stock Buybacks to Juice Price and Earnings

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Top Analyst Upgrades and Downgrades (AKS, AAPL, BBBY, BBY, CELG, CMG, FB, FURX, HBHC, HEP, NWSA, PAA, QCOM, TEX, VMW)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Celgene : CELG

All CELG Articles

Top Analyst Upgrades and Downgrades: Citigroup, Exxon, Sprint, Tiffany and More

Celgene Gets OncoMed Cancer Pipeline, Maybe Dirt Cheap

Market Take: Biotech Suffers Under Government Shutdown Too!

Top Analyst Upgrades and Downgrades: Celgene, J.C. Penney, Whole Foods and More

Top Biotechs Set to Win in the War on Cancer

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Top New Biotech Ideas From PropThink

Deutsche Bank Firm on Biotech Stocks to Buy

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Top Analyst Upgrades and Downgrades (CELG, CMCSA, FB, FFIV, JPM, JNPR, KMB, NWSA, PDCE, AET, CI, HUM, UNH, WLP)

ETF Folly: Biotech ETFs, Nothing but Confusion

Major Companies Hitting All-Time Highs! (AWK, AWR, BRK-B, UNP, HON, MMM, CELG, GOOG, CL, KMB, PG, CLX, URI, DIS)

Celgene: When Biotechs Use Stock Buybacks to Juice Price and Earnings

﻿﻿JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)

Top Analyst Upgrades and Downgrades (AKS, AAPL, BBBY, BBY, CELG, CMG, FB, FURX, HBHC, HEP, NWSA, PAA, QCOM, TEX, VMW)

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

JMP Securities Very Positive on Five Key Biotech Stocks (AMGN, BIIB, AFFY, ALNY, CELG, ONXX, PCYC, PFE, LLY, MRK, BMY)